Broadcast Med | Exclusive CAR T-Cell Clinical Trial for Advanced or Metastatic Hepatomas

A novel CAR T-cell therapy available only at Roswell Park Comprehensive Cancer Center is leveraging genome-editing technology to target the glypican-3 (GPC3) protein, which is often expressed in hepatocellular carcinoma (hepatoma) liver cancers — but rarely in healthy tissue.

💬 Read about this breakthrough clinical trial here - https://physicianresources.roswellpar...

Learn more about Dr. Davila - https://www.roswellpark.org/marco-davila

Learn more about Dr. Krishnamurthy - https://www.roswellpark.org/anuradha-...

——————————————————

To learn more about how Roswell Park can help you, or to refer your patient, fill out the form below.
https://forms.roswellpark.org/become-...